Archives

by in
Entry Author Date Location
Radius Health, Still Private, Raises Another $43M 04/25/13 Boston
East Coast Life Sciences Roundup: Bristol-Myers, Alnylam, Merck, & More 11/16/12 Boston
Xconomist of the Week: NPS’s Francois Nader Shares Lessons Learned 10/25/12 New York
Radius Fourth Boston-area Biotech This Year Going for IPO 10/24/12 Boston
Xconomist of the Week: Roger Perlmutter’s Parting Thoughts on Amgen 03/01/12 National
Mnemosyne, Hydra, On-Q-ity, & More New England Life Sciences News 02/17/12 Boston
MicroCHIPS Shows Promise of Bone Drug Implant in First Human Trial 02/16/12 Boston
Synchroneuron, Radius, Acetylon, & More Boston Life Sciences News 02/10/12 Boston
Radius Health Seeks $86M IPO 02/07/12 Boston
Turnaround CEO Shores Up Strategy for Unigene Based on Big Pharma Partnerships 11/15/11 New York
Sequenom Plans $19M Lab in North Carolina, Illumina Shares Plunge, PatientSafe Advances Device, & More San Diego Life Sciences News 10/13/11 San Diego
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News 05/27/11 Boston
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing 05/24/11 Boston
Ariad Extends Licenses, Amgen Osteoporosis Drug Meets Trial Goals, Corindus Partners with Philips, & More Boston-Area Life Sciences News 04/22/11 Boston
Amgen Passes Key Trial With “Son of Dmab” For Osteoporosis 04/21/11 National
Where Are Tomorrow’s Blockbuster Biotech Drugs Coming From? You Might be Surprised 03/14/11 National
From the Caves of Michigan’s Sleeping Bears Comes Kalamazoo’s Aursos, and a Possible New Drug for Osteoporosis 01/27/11 Detroit
Aursos Raises $40K for Osteoporosis Treatment 01/03/11 Detroit
Amgen Gets FDA Approval, SonoSite’s New Frontier, Craig Venter’s Enabler, & More Seattle-Area Life Sciences News 06/03/10 Seattle
Amgen’s Dmab Wins FDA Approval 06/01/10 Seattle
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News 10/22/09 Seattle
Amgen’s Dmab Faces FDA Delay 10/19/09 Seattle
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent 10/09/09 National
Amgen’s Dmab Works in Cancer Trial 07/07/09 Seattle
Soteira Snags $6.6M in Equity Round 05/08/09 Boston
Amgen Cuts 100 Jobs in Bothell 04/09/09 Seattle
Swype Scores $1.3M, Onehub Raises $600K, Genzyme Comes to Town, & More Seattle-Area Deals News 04/07/09 Seattle
MDRNA Sells Osteoporosis Drug 04/01/09 Seattle
Amgen Seeks FDA Nod For Bone Drug 12/19/08 Seattle
MDRNA Gets Tentative FDA Approval 12/15/08 Seattle
Page 1 of 2 next page »